Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept
- 1Division of Respirology, University Health Network and Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada
- 2Division of Infectious Diseases, University Health Network and Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada
- 3Department of Respiratory Medicine, University Health Network and Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada
- Correspondence to:
Dr Theodore K Marras
Toronto Western Hospital, 7 East, Room 452, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8; ted.marras{at}utoronto.ca
- Received 5 December 2005
- Accepted 27 February 2006
Abstract
Mycobacterium xenopi is a water-related mycobacterium with low pathogenicity in humans. Little is known about the association between anti-tumour necrosis factor (TNF)α and non-tuberculous mycobacterial infections. The case history is presented of fatal M xenopi infection in a patient receiving anti-TNFα treatment.
Footnotes
-
NM is supported by the Princess Margaret Hospital Foundation, Toronto, Canada and SACTA-RASHI Foundation, Israel.
-
Competing interests: None.









